Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Takeda Pharmaceutical Company Limited American Depositary Shares (each
(NY:
TAK
)
14.55
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Oct 6, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Takeda Pharmaceutical Company Limited American Depositary Shares (each
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Our Planet Commitment
June 15, 2021
SOURCE: Takeda
Via
3BL Media
Dreary Day
June 14, 2021
Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold.
Via
Talk Markets
The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs
June 13, 2021
Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves. The biggest biotech news of the week came in the form of approval...
Via
Talk Markets
The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs
June 13, 2021
Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves. The biggest biotech news of the week came in...
Via
Benzinga
Unheeding Markets
June 10, 2021
Today oil prices rose over $70.
Via
Talk Markets
Vertex Pharma Stumbles In Rare-Disease Effort, Buoying Rival Arrowhead Pharma
June 10, 2021
Vertex Pharmaceuticals scrapped development of a rare-disease treatment Thursday that appeared unlikely to benefit patients, and VRTX stock plunged.
Via
Investor's Business Daily
Blueprint for Access to Innovative Healthcare Episode 1: Awareness and Prevention
June 10, 2021
SOURCE: Takeda
Via
3BL Media
Wednesday News And Catch-Up
June 09, 2021
Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA.
Via
Talk Markets
Topics
Stocks
Global Diversity, Equity, and Inclusion Week at Takeda
June 08, 2021
SOURCE: Takeda
Via
3BL Media
Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)
June 07, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
How Significant Are Moderna's Asian Regulatory Wins?
June 05, 2021
The biotech is poised to profit in both Japan and South Korea.
Via
The Motley Fool
A Better Switch
June 04, 2021
Today the US market decided to rise because President Biden is pondering not linking his infrastructure project to a corporate tax increase.
Via
Talk Markets
Fan Hit
June 03, 2021
The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares.
Via
Talk Markets
Wonder Products
June 02, 2021
Meme is alive and well.
Via
Talk Markets
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
June 01, 2021
The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, the agency churned out mostly positive...
Via
Benzinga
New New Deal Worries
May 27, 2021
Nio is up 1.4% today on another round of Meme buying.
Via
Talk Markets
Good Times For Gold
May 26, 2021
Gold is rising some more, in part as an alternative to crypto.
Via
Talk Markets
Sterling At Five-Year High
May 25, 2021
Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro.
Via
Talk Markets
Takeda's Dengue Vaccine Effective In Reducing Hospitalization Regardless Of Prior Infection
May 24, 2021
Takeda Pharmaceutical Co Ltd (NYSE: TAK) unveiled long-term data for its dengue vaccine candidate (TAK-003), showing the shot’s efficacy waned over time but...
Via
Benzinga
Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
May 22, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Worldwide Upbeat
May 21, 2021
The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA.
Via
Talk Markets
Topics
Economy
Takeda's Maribavir US Application For Post-Transplant CMV Infection Under Review
May 21, 2021
The FDA has accepted for review Takeda Pharmaceutical Co Ltd's (NYSE TAK) marketing application for maribavir for cytomegalovirus (CMV) Infection. The...
Via
Benzinga
Moderna's COVID-19 Vaccine Scores Emergency Use Nod In Japan
May 21, 2021
Moderna Inc (NASDAQ: MRNA) has received emergency use approval for its mRNA COVID-19 vaccine in Japan. Takeda Pharmaceutical Co Ltd (NYSE: TAK),...
Via
Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying
May 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Is BioCryst a Good Stock to Buy Now?
May 21, 2021
This commercial-stage drugmaker trades for less than many of its clinical-stage peers.
Via
The Motley Fool
U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treatment
May 21, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Takeda Announces Approval of Moderna’s COVID-19 Vaccine in Japan
May 21, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Better Mood Day
May 20, 2021
The US Treasury plans to require IRS reporting on US cryptocurrency trades of $10,000 and up to prevent tax evasion.
Via
Talk Markets
Takeda to Present Positive Primary Analysis from Phase 2 OPTIC Trial of ICLUSIG® (ponatinib), Reinforcing Ability to Address Gaps in Care for Chronic-Phase CML
May 19, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Takeda Presents Updated Results for Mobocertinib, Further Substantiating the Clinical Benefit in Patients with EGFR Exon20 Insertion+ mNSCLC
May 19, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.